Ticker
KRROCompany Name
KORRO BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 33.61M | 1.96 | $ 17.17M |
3/31/2025 | $ 64.14M | 4.98 | $ 12.88M |
12/31/2024 | $ 55.64M | 3.72 | $ 14.96M |
9/30/2024 | $ 64.97M | 4.77 | $ 13.61M |
6/30/2024 | $ 92.92M | 7.54 | $ 12.32M |
3/31/2024 | $ 142.35M | 12.88 | $ 11.05M |
12/31/2023 | $ 169.71M | 8.71 | $ 19.48M |
9/30/2023 | $ 43.69M | 4.55 | $ 9.61M |
6/30/2023 | $ 41.67M | 5 | $ 8.33M |
3/31/2023 | $ 42.55M | 1.93 | $ 22.04M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for KORRO BIO INC is calculated as follows: CashnEq [ $ 226.05M ] / LiabilitesC [ $ 32.92M ]
(=) Cash Ratio [ 6.87 ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |